BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3152955)

  • 21. Coagulation defects caused by diphenylhydantoin.
    Solomon GE; Hilgartner MW; Kutt H
    Neurology; 1972 Nov; 22(11):1165-71. PubMed ID: 4673559
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The vitamin K-dependent proteins.
    Esnouf MP
    Biochem Soc Trans; 1979 Aug; 7(4):624-7. PubMed ID: 478110
    [No Abstract]   [Full Text] [Related]  

  • 24. Antenatal drugs affecting vitamin K status of the fetus and the newborn.
    Astedt B
    Semin Thromb Hemost; 1995; 21(4):364-70. PubMed ID: 8747699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vitamin K deficiency in the newborn].
    Muntean W
    Wien Klin Wochenschr; 1983 Jan; 95(1):1-5. PubMed ID: 6837039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of massive doses if vitamin K1 on the coagulation factors prothrombin, factor V and factor VII in liver diseases].
    GUNTHER PG; KIEFER E
    Med Klin; 1955 Nov; 50(46):1944-8. PubMed ID: 13287765
    [No Abstract]   [Full Text] [Related]  

  • 27. Supplementation of vitamin K in pregnant women receiving anticonvulsant therapy prevents neonatal vitamin K deficiency.
    Cornelissen M; Steegers-Theunissen R; Kollée L; Eskes T; Motohara K; Monnens L
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):884-8. PubMed ID: 8456897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of oral and parenteral vitamin K prophylaxis for prevention of late hemorrhagic disease of the newborn.
    Hathaway WE; Isarangkura PB; Mahasandana C; Jacobson L; Pintadit P; Pung-Amritt P; Green GM
    J Pediatr; 1991 Sep; 119(3):461-4. PubMed ID: 1880663
    [No Abstract]   [Full Text] [Related]  

  • 29. [Coagulation physiology studies on the detection of vitamin K deficiency in newborn infants with reference to preventive oral administration of vitamin K].
    Heyes H; Wenske C
    Gynakol Rundsch; 1988; 28(1):30-40. PubMed ID: 3371752
    [No Abstract]   [Full Text] [Related]  

  • 30. Maternal antenatal administration of vitamin K1 results in increasing the activities of vitamin K-dependent coagulation factors in umbilical blood and in decreasing the incidence rate of periventricular-intraventricular hemorrhage in premature infants.
    Liu J; Wang Q; Gao F; He JW; Zhao JH
    J Perinat Med; 2006; 34(2):173-6. PubMed ID: 16519625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new mixed micellar preparation for oral vitamin K prophylaxis: randomised controlled comparison with an intramuscular formulation in breast fed infants.
    Greer FR; Marshall SP; Severson RR; Smith DA; Shearer MJ; Pace DG; Joubert PH
    Arch Dis Child; 1998 Oct; 79(4):300-5. PubMed ID: 9875038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal vitamin K for low birth weight infants.
    Lazarchick J
    Int J Artif Organs; 1993 Apr; 16(4):175-6. PubMed ID: 8325692
    [No Abstract]   [Full Text] [Related]  

  • 33. Congenital deficiency of vitamin K-dependent coagulation factors associated with central nervous system anomalies.
    Puetz J; Knutsen A; Bouhasin J
    Thromb Haemost; 2004 Apr; 91(4):819-21. PubMed ID: 15045146
    [No Abstract]   [Full Text] [Related]  

  • 34. Severe deficiency of vitamin K dependent coagulation factors in an infant.
    Mickleson KN; Whyte G
    N Z Med J; 1979 Oct; 90(645):291-2. PubMed ID: 292885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maternal administration of vitamin K does not improve the coagulation profile of preterm infants.
    Kazzi NJ; Ilagan NB; Liang KC; Kazzi GM; Poland RL; Grietsell LA; Fujii Y; Brans YW
    Pediatrics; 1989 Dec; 84(6):1045-50. PubMed ID: 2587133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitamin K-dependent coagulation parameters during the first six days of life: incidence of PIVKA II in newborns.
    Boos J; Pollmann H; Dominick HC
    Pediatr Hematol Oncol; 1989; 6(2):113-9. PubMed ID: 2702065
    [TBL] [Abstract][Full Text] [Related]  

  • 37. THE ACTION OF VITAMIN K IN THE NEONATAL PERIOD.
    ABALLI AJ
    South Med J; 1965 Jan; 58():48-55. PubMed ID: 14227734
    [No Abstract]   [Full Text] [Related]  

  • 38. Vitamin K deficiency in the newborn infant: prevalence and perinatal risk factors.
    Shapiro AD; Jacobson LJ; Armon ME; Manco-Johnson MJ; Hulac P; Lane PA; Hathaway WE
    J Pediatr; 1986 Oct; 109(4):675-80. PubMed ID: 3761086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Notes on coagulation in the neonatal period. IV. Behavior of coagulation factors II, VII and X in the 1st year of life].
    Duvina PL; Simoni MR; Pieroni O
    Minerva Pediatr; 1979 Apr; 31(7):531-4. PubMed ID: 460102
    [No Abstract]   [Full Text] [Related]  

  • 40. Deficiencies in Stuart (Prower) factor, plasma thromboplastin component, prothrombin, and factor VII, due to malabsorption of vitamin K.
    HOFFMAN GC; HEWLETT JS
    Cleve Clin Q; 1959 Jan; 26(1):15-23. PubMed ID: 13639251
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.